198
Views
19
CrossRef citations to date
0
Altmetric
Review

The expanding use of matrix-assisted laser desorption/ionization-time of flight mass spectroscopy in the diagnosis of patients with mycotic diseases

&
Pages 241-248 | Received 04 Sep 2018, Accepted 23 Jan 2019, Published online: 05 Feb 2019

References

  • Douglas AP, Thursky KA, Worth LJ, et al. FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging. Eur J Nucl Med Mol Imaging. 2018;55:1121-1138.
  • Herrera S, Husain S. Early diagnosis of fungal infections in lung transplant recipients, colonization versus invasive disease? Curr Opin Organ Transplant. 2018;31:889-899.
  • Schwartz S, Kontoyiannis DP, Harrison T, et al. Advances in the diagnosis and treatment of fungal infections of the CNS. Lancet Neurol. 2018;17(4):362–372.
  • Shinozaki M, Tochigi N, Sadamoto S, et al. Histopathological diagnosis of invasive fungal infections in formalin-fixed and paraffin-embedded tissues in conjunction with molecular methods. Med Mycol J. 2018;59(1):E7–E18.
  • McCarthy M, Rosengart A, Schuetz AN, et al. Mold infections of the central nervous system. N Engl J Med. 2014;371(2):150–160.
  • McCarthy MW, Petraitiene R, Walsh TJ. Nucleic acid amplification methodologies for the detection of pulmonary mold infections. Expert Rev Mol Diagn. 2017;17(3):271–279.
  • McCarthy MW, Walsh TJ. PCR methodology and applications for the detection of human fungal pathogens. Expert Rev Mol Diagn. 2016;16(9):1025–1036.
  • Chalupová J, Raus M, Sedlářová M, et al. Identification of fungal microorganisms by MALDI-TOF mass spectrometry. Biotechnol Adv. 2014;32(1):230–241.
  • Atalay A, Koc AN, Suel A, et al. Conventional morphology versus PCR sequencing, rep-PCR, and MALDI-TOF-MS for identification of clinical aspergillus isolates collected over a 2-year period in a University Hospital at Kayseri, Turkey. J Clin Lab Anal. 2016;30(5):745–750.
  • Sanguinetti M, Posteraro B. Identification of molds by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2017;55(2):369–379.
  • Angeletti S. Matrix assisted laser desorption time of flight mass spectrometry (MALDI-TOF MS) in clinical microbiology. J Microbiol Methods. 2017;138:20–29.
  • Cassagne C, Normand AC, L’Ollivier C, et al. Performance of MALDI-TOF MS platforms for fungal identification. Mycoses. 2016;59(11):678–690.
  • Luethy PM, Zelazny AM. Rapid one-step extraction method for the identification of molds using MALDI-TOF MS. Diagn Microbiol Infect Dis. 2018;91(2):130–135.
  • Bader O. Fungal species identification by MALDI-ToF mass spectrometry. Methods Mol Biol. 2017;1508:323–337.
  • Siller-Ruiz M, Hernández-Egido S, Sánchez-Juanes F, et al. Fast methods of fungal and bacterial identification. MALDI-TOF mass spectrometry, chromogenic media. Enferm Infecc Microbiol Clin. 2017;35(5):303–313.
  • McCarthy MW, Denning DW, Walsh TJ. Future research priorities in fungal resistance. J Infect Dis. 2017;216(suppl_3):S484–S92.
  • Buchan BW, Ledeboer NA. Advances in identification of clinical yeast isolates by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2013;51(5):1359–1366.
  • Ahmad S, Khan Z. Invasive candidiasis: a review of nonculture-based laboratory diagnostic methods. Indian J Med Microbiol. 2012;30(3):264–269.
  • Panda A, Ghosh AK, Mirdha BR, et al. MALDI-TOF mass spectrometry for rapid identification of clinical fungal isolates based on ribosomal protein biomarkers. J Microbiol Methods. 2015;109:93–105.
  • McMullen AR, Wallace MA, Pincus DH, et al. Evaluation of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of clinically relevant filamentous fungi. J Clin Microbiol. 2016;54(8):2068–2073.
  • Bao JR, Master RN, Azad KN, et al. Rapid, accurate identification of candida auris by using a novel matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) database (Library). J Clin Microbiol. 2018;56:4.
  • Lamoth F, Kontoyiannis DP. The Candida auris alert: facts and perspective. J Infect Dis. 2018;217(4):516–520.
  • McCarthy MW, Walsh TJ. Drug development challenges and strategies to address emerging and resistant fungal pathogens. Expert Rev Anti Infect Ther. 2017;15(6):577–584.
  • Desoubeaux G, É B, Guillaume C, et al. Candida auris in contemporary mycology labs: a few practical tricks to identify it reliably according to one recent French experience. J Mycol Med. 2018;29:636-651.
  • McCarthy MW, Walsh TJ. Drugs currently under investigation for the treatment of invasive candidiasis. Expert Opin Investig Drugs. 2017;26(7):825–831.
  • Aguiar PADF, Pedroso RDS, Borges AS, et al. The epidemiology of cryptococcosis and the characterization of Cryptococcus neoformans isolated in a Brazilian University Hospital. Rev Inst Med Trop Sao Paulo. 2017;59:e13.
  • Chen Y, Farrer RA, Giamberardino C, et al. Microevolution of serial clinical isolates of Cryptococcus neoformans vargrubii and C gattii. MBio. 2017;8:2.
  • Chen M, Xu Y, Hong N, et al. Epidemiology of fungal infections in China. Front Med. 2018;12(1):58–75.
  • Yaman G, Akyar I, Can S. Evaluation of the MALDI TOF-MS method for identification of Candida strains isolated from blood cultures. Diagn Microbiol Infect Dis. 2012;73(1):65–67.
  • Spanu T, Posteraro B, Fiori B, et al. Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories. J Clin Microbiol. 2012;50(1):176–179.
  • Pulcrano G, Iula DV, Vollaro A, et al. Rapid and reliable MALDI-TOF mass spectrometry identification of Candida non-albicans isolates from bloodstream infections. J Microbiol Methods. 2013;94(3):262–266.
  • Ghosh AK, Paul S, Sood P, et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections. Clin Microbiol Infect. 2015;21(4):372–378.
  • Vatanshenassan M, Boekhout T, Lass-Flörl C, et al. Proof of concept for MBT ASTRA, a rapid matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)-based method to detect caspofungin resistance in Candida albicans and Candida glabrata. J Clin Microbiol. 2018;56:9.
  • Vella A, De Carolis E, Mello E, et al. Potential use of MALDI-ToF mass spectrometry for rapid detection of antifungal resistance in the human pathogen Candida glabrata. Sci Rep. 2017;7(1):9099.
  • Posteraro B, De Carolis E, Vella A, et al. MALDI-TOF mass spectrometry in the clinical mycology laboratory: identification of fungi and beyond. Expert Rev Proteomics. 2013;10(2):151–164.
  • Paul S, Singh P. Rudramurthy SM, et al.Rapid detection of fluconazole resistance in Candida tropicalis by MALDI-TOF MS. Med Mycol. 2018;56(2):234–241.
  • Aslani N, Janbabaei G, Abastabar M, et al. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry. BMC Infect Dis. 2018;18(1):24.
  • Perfect JR. Cryptococcosis: a model for the understanding of infectious diseases. J Clin Invest. 2014;124(5):1893–1895.
  • Perfect JR, Bicanic T. Cryptococcosis diagnosis and treatment: what do we know now. Fungal Genet Biol. 2015;78:49–54.
  • McTaggart LR, Lei E, Richardson SE, et al. Rapid identification of Cryptococcus neoformans and Cryptococcus gattii by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2011;49(8):3050–3053.
  • Tarumoto N, Sakai J, Kodana M, et al. Identification of disseminated Cryptococcosis using MALDI-TOF MS and clinical evaluation. Med Mycol J. 2016;57(3):E41–6.
  • Lee HS, Shin JH, Choi MJ, et al. Comparison of the bruker biotyper and VITEK MS matrix-assisted laser desorption/ionization time-of-flight mass spectrometry systems using a formic acid extraction method to identify common and uncommon yeast isolates. Ann Lab Med. 2017;37(3):223–230.
  • Vlek A, Kolecka A, Khayhan K, et al. Interlaboratory comparison of sample preparation methods, database expansions, and cutoff values for identification of yeasts by matrix-assisted laser desorption ionization-time of flight mass spectrometry using a yeast test panel. J Clin Microbiol. 2014;52(8):3023–3029.
  • Taverna CG, Mazza M, Bueno NS, et al. Development and validation of an extended database for yeast identification by MALDI-TOF MS in Argentina. Med Mycol. 2018;19:771-782.
  • Shaukat A, Bakri F, Young P, et al. Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics. Mycopathologia. 2005;159(2):181–188.
  • Schulthess B, Ledermann R, Mouttet F, et al. Use of the bruker MALDI biotyper for identification of molds in the clinical mycology laboratory. J Clin Microbiol. 2014;52(8):2797–2803.
  • Alanio A, Bretagne S. Challenges in microbiological diagnosis of invasive Aspergillus infections. F1000Res. 2017;6:554-571.
  • Segal BH. Aspergillosis. N Engl J Med. 2009;360(18):1870–1884.
  • Vidal-Acuña MR, Ruiz-Pérez de Pipaón M, Torres-Sánchez MJ, et al. Identification of clinical isolates of Aspergillus, including cryptic species, by matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). Med Mycol. 2017;32:611-622.
  • Masih A, Singh PK, Kathuria S, et al. Identification by molecular methods and matrix-assisted laser desorption ionization-time of flight mass spectrometry and antifungal susceptibility profiles of clinically significant rare Aspergillus species in a referral chest hospital in Delhi, India. J Clin Microbiol. 2016;54(9):2354–2364.
  • Nakamura S, Sato H, Tanaka R, et al. Ribosomal subunit protein typing using matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) for the identification and discrimination of Aspergillus species. BMC Microbiol. 2017;17(1):100.
  • Nakamura S, Sato H, Tanaka R, et al. Verification of ribosomal proteins of mass spectrom (Tokyo). Mycoses. 2016;5(1):A0049.
  • Ibrahim AS, Kontoyiannis DP. Update on mucormycosis pathogenesis. Curr Opin Infect Dis. 2013;26(6):508–515.
  • Shao J, Wan Z, Li R, et al. Species identification and delineation of pathogenic mucorales by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2018;56:4.
  • De Carolis E, Vella A, Florio AR, et al. Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species. J Clin Microbiol. 2012;50(7):2479–2483.
  • Cronjé N, Schwartz IS, Retief L, et al. Attempted molecular detection of the thermally dimorphic human fungal pathogen emergomyces africanus in terrestrial small mammals in South Africa. Med Mycol. 2018;56(4):510–513.
  • Chu JH, Feudtner C, Heydon K, et al. Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis. 2006;42(6):822–825.
  • Valero C, Buitrago MJ, Gago S, et al. A matrix-assisted laser desorption/ionization time of flight mass spectrometry reference database for the identification of Histoplasma capsulatum. Med Mycol. 2018;56(3):307–314.
  • Weber SS, Parente AF, Borges CL, et al. Analysis of the secretomes of Paracoccidioides mycelia and yeast cells. PLoS One. 2012;7(12):e52470.
  • Nobrega de Almeida J, Del Negro GM, Grenfell RC, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for differentiation of the dimorphic fungal species Paracoccidioides brasiliensis and Paracoccidioides lutzii. J Clin Microbiol. 2015;53(4):1383–1386.
  • Zhang Z, Hou B, Xin Y, et al. Protein profiling of the dimorphic pathogenic fungus, Sporothrix schenckii. Mycopathologia. 2012;173(1):1–11.
  • Del Chierico F, Masotti A, Onori M, et al. MALDI-TOF MS proteomic phenotyping of filamentous and other fungi from clinical origin. J Proteomics. 2012;75(11):3314–3330.
  • Honnavar P, Ghosh AK, Paul S, et al. Identification of Malassezia species by MALDI-TOF MS after expansion of database. Diagn Microbiol Infect Dis. 2018;32:543-555.
  • Berger AP, Ford BA, Brown-Joel Z, et al. Angioinvasive Fungal infections impacting the skin: diagnosis, Management, and Complications (Part 2). J Am Acad Dermatol. 2018;17:221-232.
  • Osherov N, Kontoyiannis DP. The anti-Aspergillus drug pipeline: is the glass half full or empty? Med Mycol. 2017;55(1):118–124.
  • Perfect JR. The antifungal pipeline: a reality check. Nat Rev Drug Discov. 2017.
  • Bai J, Zhang P, Bao G, et al. Imaging mass spectrometry-guided fast identification of antifungal secondary metabolites from Penicillium polonicum. Appl Microbiol Biotechnol. 2018.
  • Da Cunha KC, Riat A, Normand AC, et al. Fast identification of dermatophytes by MALDI-TOF/MS using direct transfer of fungal cells on ground steel target plates. Mycoses. 2018;44:331-345.
  • Zvezdanova ME, Escribano P, Ruiz A, et al. Increased species-assignment of filamentous fungi using MALDI-TOF MS coupled with a simplified sample processing and an in-house library. Med Mycol. 2018;18:991-999.
  • Bille E, Dauphin B, Leto J, et al. MALDI-TOF MS andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp and positive blood cultures. Clin Microbiol Infect. 2012;18(11):1117–1125.
  • L’Ollivier C, Cassagne C, Normand AC, et al. A MALDI-TOF MS procedure for clinical dermatophyte species identification in the routine laboratory. Med Mycol. 2013;51(7):713–720.
  • Vrioni G, Tsiamis C, Oikonomidis G, et al. MALDI-TOF mass spectrometry technology for detecting biomarkers of antimicrobial resistance: current achievements and future perspectives. Ann Transl Med. 2018;6(12):240.
  • Genc GE, Demir M, Yaman G, et al. Evaluation of MALDI-TOF MS for identification of nontuberculous mycobacteria isolated from clinical specimens in mycobacteria growth indicator tube medium. New Microbiol. 2018;41(3):214–219.
  • Costa-Alcalde JJ, Barbeito-Castiñeiras G, González-Alba JM, et al. Comparative evaluation of the identification of rapidly growing non-tuberculous mycobacteria by mass spectrometry (MALDI-TOF MS), GenoType Mycobacterium CM/AS assay and partial sequencing of the rpoβ gene with phylogenetic analysis as a reference method. Enferm Infecc Microbiol Clin. 2018;8:222-232.
  • Popp R, Li H, Borchers CH. Immuno-MALDI (iMALDI) mass spectrometry for the analysis of proteins in signalling pathways. Expert Rev Proteomics. 2018;24:608-622.
  • Patterson TF, Thompson GR, Denning DW, et al. Executive summary: practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;63(4):433–442.
  • Sendid B, Poissy J, François N, et al. Preliminary evidence for a serum disaccharide signature of invasive Candida albicans infection detected by MALDI mass spectrometry. Clin Microbiol Infect. 2015;21(1):88.e1–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.